• 
  Samuel J. Dicken, Christina C. Dahm, Daniel B. Ibsen, Anja Olsen, Anne Tjønneland, et al.. Food consumption by degree of food processing and risk of type 2 diabetes mellitus: a prospective cohort analysis of the European Prospective Investigation into Cancer and Nutrition (EPIC). The Lancet Regional Health - Europe, 2024, 46, ⟨10.1016/j.lanepe.2024.101043⟩. ⟨hal-04831663⟩
• 
  Sébastien Mulé, Littisha Lawrance, Younes Belkouchi, Valérie Vilgrain, Maité Lewin, et al.. Generative adversarial networks (GAN)-based data augmentation of rare liver cancers: The SFR 2021 Artificial Intelligence Data Challenge. Diagnostic and Interventional Imaging, 2023, 104 (1), pp.43-48. ⟨10.1016/j.diii.2022.09.005⟩. ⟨hal-03907631⟩
• 
  Sophie Renet, Marie-Camille Chaumais, Mélanie Gallant-Dewavrin, Emmanuelle Jouet, Yvonnick Bezie, et al.. Knowledge exchange between patient and pharmacist: a mixed methods study to explore the role of pharmacists in patient education and counselling in asthma and pulmonary arterial hypertension. Annales Pharmaceutiques Françaises, 2022, ⟨10.1016/j.pharma.2022.06.005⟩. ⟨hal-03712124⟩
• 
  Romain Darrigrand, Alison Pierson, Marine Rouillon, Dolor Renko, Mathilde Boulpicante, et al.. Isoginkgetin derivative IP2 enhances the adaptive immune response against tumor antigens. Communications Biology, 2021, 4 (1), pp.269. ⟨10.1038/s42003-021-01801-2⟩. ⟨hal-03396797⟩
• 
  Anne Helbling-Leclerc, Marie Falampin, Abdelkader Heddar, Léa Guerrini-Rousseau, Maud Marchand, et al.. Biallelic Germline BRCA1 Frameshift Mutations Associated with Isolated Diminished Ovarian Reserve. International Journal of Molecular Sciences, 2024, 25 (22), pp.12460. ⟨10.3390/ijms252212460⟩. ⟨hal-04800742⟩
• 
  Anqi Wang, Jiayi Shen, Alex Rodriguez, Edward Saunders, Fei Chen, et al.. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nature Genetics, 2023, 55 (12), pp.2065-2074. ⟨10.1038/s41588-023-01534-4⟩. ⟨hal-04361167⟩
• 
  Jean-Edouard Martin, Sabine Khalife-Hachem, Maria Kfoury, Sylvain Garciaz, Florence Pasquier, et al.. Therapy Related Myeloid Neoplasm Post PARP Inhibitors: Potential Clonal Selection.. Blood, 2020, 136 (Supplement 1), pp.14-15. ⟨10.1182/blood-2020-139971⟩. ⟨hal-04843422⟩
• 
  Killian Laguerre, Giorgia Urbinati, Ruxandra Gref. MULTIFUNCTIONAL NANOPARTICLES TO FIGHT HORMONE-RESISTANT PROSTATE CANCER. 10th Annual Meeting of SFNano, Societé Française de Nanomédicine, Dec 2024, Toulouse, France. pp.24. ⟨hal-04831942⟩
• 
  Marie Pierre Castex, Joanna Stefanowicz, Laura Clement, Jadwiga Węcławek-Tompol, Frederic Hameury, et al.. Choriocarcinoma in neonates and infants: A severe but curable disease. Pediatric Blood and Cancer, 2024, 71 (8), ⟨10.1002/pbc.31124⟩. ⟨hal-04822550⟩
• 
  Olivier Thouvenin, Jules Scholler, Diana Mandache, Marie Christine Mathieu, Aïcha Ben Lakhdar, et al.. Automatic diagnosis and biopsy classification with dynamic Full-Field OCT and machine learning. 2021. ⟨hal-03781375⟩
• 
  Maud Voisin, Philippe de Médina, Arnaud Mallinger, Florence Dalenc, Emilie Huc-Claustre, et al.. Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor. Proceedings of the National Academy of Sciences of the United States of America, 2017, 114 (44), pp.E9346-E9355. ⟨10.1073/pnas.1707965114⟩. ⟨hal-02316171⟩
• 
  Faten Merhi, Karla Alvarez-Valadez, Jenifer Trepiana, Claire Lescoat, Alexis Groppi, et al.. Targeting CAMKK2 and SOC Channels as a Novel Therapeutic Approach for Sensitizing Acute Promyelocytic Leukemia Cells to All-Trans Retinoic Acid. Cells, 2021, 10 (12), pp.3364. ⟨10.3390/cells10123364⟩. ⟨hal-03457279⟩
• 
  Giuseppe Arena, Madi Yann Cisse, Samuel Pyrdziak, Laurent Chatre, Romain Riscal, et al.. Mitochondrial MDM2 regulates respiratory complex i activity independently of p53. Molecular Cell, 2018, 69 (4), pp.594-609. ⟨10.1016/j.molcel.2018.01.023⟩. ⟨hal-01837662⟩
• 
  Aygun Imanci. L'implication des suppresseurs de tumeur, TET2 et TP53, dans l'évolution et le traitement de la Leucémie myélomonocytaire Chronique. Cancer. Université Paris-Saclay, 2023. Français. ⟨NNT : 2023UPASL113⟩. ⟨tel-04485463⟩
• 
  Pascal-Alexandre Thomas, Anne-Laure Couderc, David Boulate, Laurent Greillier, Aude Charvet, et al.. Early-stage non-small cell lung cancer beyond life expectancy: Still not too old for surgery?. Lung Cancer, 2021, 152, pp.86-93. ⟨10.1016/j.lungcan.2020.12.009⟩. ⟨hal-03526487⟩
• 
  Dorian Culié, Quentin Lisan, Charlotte Leroy, Anouchka Modesto, Renaud Schiappa, et al.. Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric study. European journal of cancer, 1970, 143, pp.168-177. ⟨10.1016/j.ejca.2020.10.034⟩. ⟨hal-03618860⟩
• 
  Jean-Emmanuel Kurtz, Xavier Buy, Frédéric Deschamps, Erik Sauleau, Amine Bouhamama, et al.. CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment. European Journal of Cancer, 2021, 143, pp.78-87. ⟨10.1016/j.ejca.2020.10.035⟩. ⟨hal-03623642⟩
• 
  Sylvain Manfredi, Anthony Turpin, David Malka, Emilie Barbier, Pierre Laurent-Puig, et al.. Maintenance treatment with fluoropyrimidine plus bevacizumab versus fluoropyrimidine alone after induction chemotherapy for metastatic colorectal cancer: The BEVAMAINT - PRODIGE 71 - (FFCD 1710) phase III study. Digestive and Liver Disease, 2020, 52 (10), pp.1143-1147. ⟨10.1016/j.dld.2020.06.034⟩. ⟨hal-04548048⟩
• 
  Sarah Atallah, Odile Casiraghi, Nicolas Fakhry, Michel Wassef, Emmanuelle Uro-Coste, et al.. A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors. European journal of cancer, 2020, 130, pp.241-249. ⟨10.1016/j.ejca.2020.01.023⟩. ⟨hal-03599053⟩
• 
  F. Mosele, B. Stefanovska, A. Lusque, A. Tran Dien, I. Garberis, et al.. Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer. Annals of Oncology, 2020, 31 (3), pp.377-386. ⟨10.1016/j.annonc.2019.11.006⟩. ⟨hal-04522293⟩

2 595

2 580